Shugo Tamada

820 total citations
14 papers, 660 citations indexed

About

Shugo Tamada is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Shugo Tamada has authored 14 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Shugo Tamada's work include Glycosylation and Glycoproteins Research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Breast Cancer Treatment Studies (4 papers). Shugo Tamada is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Breast Cancer Treatment Studies (4 papers). Shugo Tamada collaborates with scholars based in Japan, United States and India. Shugo Tamada's co-authors include Masamichi Goto, Surinder K. Batra, Suguru Yonezawa, Hiroaki Shibahara, Kohzoh Imai, Michael A. Hollingsworth, Michiyo Higashi, Yasuaki Sagara, Yuji Nimura and Koji Oda and has published in prestigious journals such as Hepatology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Shugo Tamada

13 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shugo Tamada Japan	9	339	330	321	118	108	14	660
Kei Ijichi Japan	16	412 1.2×	189 0.6×	528 1.6×	102 0.9×	143 1.3×	41	802
G. B. Snow Netherlands	12	195 0.6×	286 0.9×	338 1.1×	129 1.1×	48 0.4×	17	788
Masahiko Osako Japan	9	411 1.2×	329 1.0×	500 1.6×	66 0.6×	44 0.4×	19	747
Matthew D. Stachler United States	15	340 1.0×	344 1.0×	320 1.0×	98 0.8×	84 0.8×	38	911
Fabiana Bettoni Brazil	15	113 0.3×	247 0.7×	273 0.9×	173 1.5×	88 0.8×	30	557
C. Cordon‐Cardo United States	7	446 1.3×	376 1.1×	338 1.1×	159 1.3×	51 0.5×	8	809
Zhiming Dong China	14	158 0.5×	244 0.7×	294 0.9×	177 1.5×	189 1.8×	32	688
Toshimasa Kihana Japan	13	180 0.5×	265 0.8×	368 1.1×	159 1.3×	228 2.1×	15	703
Hua-Qing Min China	9	323 1.0×	237 0.7×	314 1.0×	126 1.1×	32 0.3×	13	787
Joël Gsponer Switzerland	11	273 0.8×	213 0.6×	242 0.8×	160 1.4×	74 0.7×	17	675

Countries citing papers authored by Shugo Tamada

Since Specialization

Citations

This map shows the geographic impact of Shugo Tamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shugo Tamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shugo Tamada more than expected).

Fields of papers citing papers by Shugo Tamada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shugo Tamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shugo Tamada. The network helps show where Shugo Tamada may publish in the future.

Co-authorship network of co-authors of Shugo Tamada

This figure shows the co-authorship network connecting the top 25 collaborators of Shugo Tamada. A scholar is included among the top collaborators of Shugo Tamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shugo Tamada. Shugo Tamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Umekita, Yoshihisa, Yasuyo Ohi, Masakazu Souda, et al.. (2018). Maspin mRNA expression in sentinel lymph nodes predicts non‐SLN metastasis in breast cancer patients with SLN metastasis. Histopathology. 73(6). 916–922. 2 indexed citations

Ohi, Yasuyo, Yoshihisa Umekita, Yasuaki Sagara, et al.. (2012). Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer. British Journal of Cancer. 107(8). 1239–1243. 40 indexed citations

Rai, Yoshiaki, Yasuyo Ohi, Yasuaki Sagara, et al.. (2012). 519 Intraoperative One-step Nucleic Acid Amplification Assay(OSNA) to Detect Sentinel Lymph Node(SLN) Metastasis in Breast Cancer–an Evaluation of 703 Cases in a Single Institution. European Journal of Cancer. 48. S198–S198. 3 indexed citations

Sagara, Yasuaki, Yasuyo Ohi, Daisuke Yotsumoto, et al.. (2011). Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer. Breast Cancer. 20(2). 181–186. 37 indexed citations

Umekita, Yoshihisa, Yasuyo Ohi, Masakazu Souda, et al.. (2011). Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer. Diagnostic Pathology. 6(1). 36–36. 25 indexed citations

Ohi, Yasuyo, Yoshihisa Umekita, Yoshiaki Rai, et al.. (2011). Mucocele-like lesions of the breast: a long-term follow-up study. Diagnostic Pathology. 6(1). 29–29. 12 indexed citations

Tamada, Shugo, et al.. (2011). [A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy].. PubMed. 38(4). 635–7.

Sagara, Yasuaki, Shinichi Baba, Shugo Tamada, et al.. (2009). Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients. Breast Cancer. 17(3). 212–217. 8 indexed citations

Tamada, Shugo, Hiroaki Shibahara, Michiyo Higashi, et al.. (2006). MUC4 Is a Novel Prognostic Factor of Extrahepatic Bile Duct Carcinoma. Clinical Cancer Research. 12(14). 4257–4264. 78 indexed citations

10.

Goto, Masamichi, Hiroaki Shibahara, Shugo Tamada, et al.. (2005). Aberrant expression of pyloric gland‐type mucin in mucin‐producing bile duct carcinomas: A clear difference between the core peptide and the carbohydrate moiety. Pathology International. 55(8). 464–470. 6 indexed citations

11.

Goto, Masamichi, Michiko Horinouchi, Shugo Tamada, et al.. (2005). MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. Journal of Clinical Pathology. 58(8). 845–852. 127 indexed citations

12.

Shibahara, Hiroaki, Shugo Tamada, Masamichi Goto, et al.. (2004). Pathologic Features of Mucin-producing Bile Duct Tumors. The American Journal of Surgical Pathology. 28(3). 327–338. 134 indexed citations

13.

Shibahara, Hiroaki, Shugo Tamada, Michiyo Higashi, et al.. (2004). MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology. 39(1). 220–229. 121 indexed citations

14.

Tamada, Shugo, Masamichi Goto, Mitsuharu Nomoto, et al.. (2002). Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis. Pathology International. 52(11). 713–723. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact